SCHEMBL30004306

SCHEMBL30004306

C[C@H](Nc1ccc(Cl)c2ccccc12)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
IDO1 P14902 4/20 0.44
TSHR P16473 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2A6 P11509 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 3/20 0.42
BBOX1 O75936 2/20 0.42
EGLN1 Q9GZT9 2/20 0.42
FTO Q9C0B1 1/20 0.42
KMT2A Q03164 2/20 0.41
ATM Q13315 1/20 0.41
MAPT P10636 1/20 0.40
LMNA P02545 3/20 0.39
CXCL8 P10145 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3512380 0.81 LMNA (0.48) KEAP1NFE2L2IDO1ALDH1A1KMT2A
SCHEMBL3512382 0.81 LMNA (0.48) KEAP1NFE2L2IDO1ALDH1A1KMT2A
SCHEMBL5022885 0.80 CXCL8 (0.50) TSHRCYP1A2NPC1RAB9AALDH1A1
SCHEMBL2941689 0.80 CXCL8 (0.50) TSHRCYP1A2NPC1RAB9AALDH1A1
SCHEMBL14444100 0.79 IDO1 (0.61) IDO1TSHRCYP1A2CYP2A6NPC1
SCHEMBL42286 0.77 CA12 (0.54) KEAP1TSHRCYP1A2NPC1RAB9A
SCHEMBL409050 0.77 CA12 (0.54) KEAP1TSHRCYP1A2NPC1RAB9A
SCHEMBL42287 0.77 CA12 (0.54) KEAP1TSHRCYP1A2NPC1RAB9A
SCHEMBL29367675 0.77 CA12 (0.54) KEAP1TSHRCYP1A2NPC1RAB9A
SCHEMBL298855 0.77 CA12 (0.54) KEAP1TSHRCYP1A2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11866518-B2 Bicyclic peptide ligands specific for TSLP BICYCLETX LIMITED (GB) 2024-01-09 US disclosed
CN-115768456-A TSLP-specific bicyclic peptide ligands 拜斯科技术开发有限公司 2023-03-07 CN disclosed
EP-4132481-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TSLP BicycleTX Limited (GB) 2023-02-15 EP disclosed
US-20220363718-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TSLP BICYCLETX LIMITED (GB) 2022-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363718-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TSLP TSLP, VIP, CCL2 KEAP1 2200/4885NFE2L2 3825/4885IDO1 1467/4885
US-11866518-B2 Bicyclic peptide ligands specific for TSLP TSLP, VIP, CCL2 KEAP1 2200/4885NFE2L2 3825/4885IDO1 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.